Fujifilm doubles down on ex-Biogen facility with $928M infusion as biotech boom fuels CDMO growth

Almost a year after bagging a Biogen manufacturing subsidiary in Denmark for $890 million, Fujifilm is investing even more — to the tune of $928 million — to ramp up its biologics production capacity there.